Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

NCT07028125 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma (Kidney Cancer)
Metastatic Renal Cell Carcinoma
Locally Advanced

Interventions

DRUG: cabozantinib and nivolumab

Sponsor

Centre Francois Baclesse